These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
105 related items for PubMed ID: 24601159
1. Pharmacoeconomic impact evaluation of statin adherence in high-risk unselected post myocardial infarction population: an administrative database-guided analysis. Summaria F, Ciaralli F, Mustilli M, Sette A, Lanzillo C, Vasselli L. Med Arch; 2013; 67(5):314-7. PubMed ID: 24601159 [Abstract] [Full Text] [Related]
2. Statin Discontinuation, Reinitiation, and Persistence Patterns Among Medicare Beneficiaries After Myocardial Infarction: A Cohort Study. Booth JN, Colantonio LD, Chen L, Rosenson RS, Monda KL, Safford MM, Kilgore ML, Brown TM, Taylor B, Dent R, Muntner P, Levitan EB. Circ Cardiovasc Qual Outcomes; 2017 Oct; 10(10):. PubMed ID: 29021332 [Abstract] [Full Text] [Related]
3. Impact of the 2013 American College of Cardiology/American Heart Association cholesterol guidelines on the prescription of high-intensity statins in patients hospitalized for acute coronary syndrome or stroke. Valentino M, Al Danaf J, Panakos A, Ragupathi L, Duffy D, Whellan D. Am Heart J; 2016 Nov; 181():130-136. PubMed ID: 27823684 [Abstract] [Full Text] [Related]
4. Repeat prescriptions of guideline-based secondary prevention medication in patients with type 2 diabetes and previous myocardial infarction in Dutch primary care. Kasteleyn MJ, Wezendonk A, Vos RC, Numans ME, Jansen H, Rutten GE. Fam Pract; 2014 Dec; 31(6):688-93. PubMed ID: 25106412 [Abstract] [Full Text] [Related]
5. Evaluation of the prescription and utilization patterns of statins in an Italian local health unit during the period 1994-2003. Deambrosis P, Saramin C, Terrazzani G, Scaldaferri L, Debetto P, Giusti P, Chinellato A. Eur J Clin Pharmacol; 2007 Feb; 63(2):197-203. PubMed ID: 17200832 [Abstract] [Full Text] [Related]
6. Understanding adherence to therapeutic guidelines: a multilevel analysis of statin prescription in the Skaraborg Primary Care Database. Hjerpe P, Ohlsson H, Lindblad U, Boström KB, Merlo J. Eur J Clin Pharmacol; 2011 Apr; 67(4):415-423. PubMed ID: 21190018 [Abstract] [Full Text] [Related]
11. Patient and physician predictors of hyperlipidemia screening and statin prescription. Kannan S, Asch DA, Kurtzman GW, Honeywell S, Day SC, Patel MS. Am J Manag Care; 2018 Aug 01; 24(8):e241-e248. PubMed ID: 30130024 [Abstract] [Full Text] [Related]
12. Patient adherence to generic versus brand statin therapy after acute myocardial infarction: Insights from the Can Rapid Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the American College of Cardiology/American Heart Association Guidelines Registry. O'Brien EC, McCoy LA, Thomas L, Peterson ED, Wang TY. Am Heart J; 2015 Jul 01; 170(1):55-61. PubMed ID: 26093864 [Abstract] [Full Text] [Related]
13. Longitudinal persistence with secondary prevention therapies relative to patient risk after myocardial infarction. Shore S, Jones PG, Maddox TM, Bradley SM, Stolker JM, Arnold SV, Parashar S, Peterson P, Bhatt DL, Spertus J, Ho PM. Heart; 2015 May 15; 101(10):800-7. PubMed ID: 25801001 [Abstract] [Full Text] [Related]
14. Optimal pharmacological treatment and adherence to medication in secondary prevention of cardiovascular events in Spain: Results from the CAPS study. Cordero A, Rodriguez Padial L, Batalla A, López Barreiro L, Torres Calvo F, Castellano JM, Ruiz E, Bertomeu-Martínez V, CAPS study investigators. Cardiovasc Ther; 2017 Apr 15; 35(2):. PubMed ID: 27957818 [Abstract] [Full Text] [Related]
15. Statin Utilization Patterns and Outcomes for Patients with Acute Coronary Syndrome During and Following Inpatient Admissions. Boklage SH, Malangone-Monaco E, Lopez-Gonzalez L, Ding Y, Henriques C, Elassal J. Cardiovasc Drugs Ther; 2018 Jun 15; 32(3):273-280. PubMed ID: 29855748 [Abstract] [Full Text] [Related]
17. Statin prescribing according to gender, age and indication: what about the benefit-risk balance? Wallach-Kildemoes H, Stovring H, Holme Hansen E, Howse K, Pétursson H. J Eval Clin Pract; 2016 Apr 15; 22(2):235-46. PubMed ID: 26446680 [Abstract] [Full Text] [Related]
18. Secondary prevention for coronary artery disease: are we following the guidelines? Syed IA, Riaz A, Ryan A, Reilly MO. Ir J Med Sci; 2010 Dec 15; 179(4):535-7. PubMed ID: 20676796 [Abstract] [Full Text] [Related]